查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1362873

女性健康诊断市场规模、份额和趋势分析报告：按最终用途、用途、地区和细分市场预测，2023-2030 年

Women's Health Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Application(Cancer, Infectious Disease, Osteoporosis, Pregnancy & Fertility, Prenatal), By Region And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

女性健康诊断市场的成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球女性健康诊断市场预计将达到 314 亿美元。

预计2023年至2030年该市场将以7.3%的年复合成长率扩张。越来越多地采用现场诊断、各种慢性病和文明病的罹患率是刺激市场成长的主要要素。除此之外，预计各种宣传计画的推出也将在预测期内有利于市场。例如，2014年，欧盟委员会联合推出了《欧洲提高癌症综合控製品质指南》。

由于各组织的资金增加，女性健康诊断显示出高速成长。例如，2015年5月，Abcodia与Cambridge Innovative Capital、Scottish Equity Partners和Albion Ventures合作，在英国推出用于早期发现卵巢癌的卵巢癌风险演算法（ROCA）测试，获得了800万美元的资金加州大学洛杉矶分校。

依最终用途，市场分为医院/诊断中心和家庭使用。由于医院就诊次数多且检测更可靠，医院和诊断中心占据了很大的市场。

亚太市场在未来年度可能会显着成长。该市场的成长是由医疗保健投资的增加、国际设备製造商专注于加强其在该地区的销售网络以及该地区流行病学从感染疾病到慢性病的不断转变所推动的，这是由于持续的转变。

女性健康诊断市场报告亮点

  • 政府和私人实体投资的增加以及可支配所得的增加正在提振市场。
  • 2017年癌症的市场占有率最高。由于早期检测测试的可用性和政府针对癌症的配合措施，该领域将在预测期内出现显着增长。
  • 由于产前疾病患病上升、孕产妇年龄增加、医疗保健支出迅速增加以及先进诊断测试的发展，产前检测预计将成为同期成长最快的部分。
  • 按地区划分，北美占市场主导地位，2022 年收益占有率最大，为 44.87%。由于诊断中心和影像中心基础的扩大、癌症患者数量的增加、不孕检测意识的提高以及护理点的快速普及，预计该市场将保持主导地位到2025年检测设备.马苏.

目录

第1章调查方法与范围

第2章执行摘要

第3章：女性健康诊断市场的变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 女性健康诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 主要交易及策略联盟分析
    • 打入市场策略

第4章女性健康诊断：用途估算及趋势分析

  • 女性健康诊断市场：重点
  • 女性健康诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 癌症
    • 2018年至2030年癌症市场估计与预测
  • 感染疾病
    • 2018年至2030年感染疾病市场估计与预测
  • 骨质疏鬆症
    • 2018年至2030年骨质疏鬆症市场估计与预测
  • 怀孕和生育
    • 2018 年至 2030 年怀孕和生育市场估计和预测
  • 产前
    • 2018年至2030年产前市场估计与预测

第5章妇女健康诊断：最终用途估计与趋势分析

  • 女性健康诊断市场：重点
  • 女性健康诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 医院
  • 实验室
  • 居家照护
  • 其他的

第6章女性健康诊断市场：区域估算与趋势分析

  • 区域预测
  • 按地区分類的女性健康诊断市场：市场要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • F. Hoffmann-la Roche Ltd.
    • Siemens Aktiengeselischaft
    • Quest Diagnostics incorporated
    • Ge Healthcare
    • Koninklijke Philips NV
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Hologic, Inc.
Product Code: GVR-2-68038-581-6

Women's Health Diagnostics Market Growth & Trends:

The global women's health diagnostics market size is expected to reach USD 31.4 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 7.3% from 2023 to 2030. Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period. For instance, in 2014, the European Commission launched joint action for European Guide on Quality Improvement in Comprehensive Cancer Control.

Women's health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.

On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.

Women's Health Diagnostics Market Report Highlights:

  • Increasing investments by governments and private bodies and rising disposable income are providing a push to the market
  • Cancer accounted for the highest share in the market in 2017. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer
  • Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests
  • Geographically, North America dominated the market and accounted for the largest revenue share of 44.87% in 2022. It is anticipated to maintain its dominance through 2025, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. End-use
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Women's Health Diagnostic Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Women's Health Diagnostic Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
    • 3.4.3. Major Deals & Strategic Alliances Analysis
    • 3.4.4. Market Entry Strategies

Chapter 4. Women's Health Diagnostic: Application Estimates & Trend Analysis

  • 4.1. Women's Health Diagnostic Market: Key Takeaways
  • 4.2. Women's Health Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Cancer
    • 4.3.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Infectious diseases
    • 4.4.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Osteoporosis
    • 4.5.1. Osteoporosis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Pregnancy & fertility
    • 4.6.1. Pregnancy & fertility market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Prenatal
    • 4.7.1. Prenatal market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Women's Health Diagnostic: End-use Estimates & Trend Analysis

  • 5.1. Women's Health Diagnostic Market: Key Takeaways
  • 5.2. Women's Health Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Laboratory
    • 5.4.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Homecare
    • 5.5.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Women's Health Diagnostic Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Women's Health Diagnostic Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. F. Hoffmann-la Roche Ltd.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Siemens Aktiengeselischaft
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Quest Diagnostics incorporated
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Ge Healthcare
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Koninklijke Philips N.V.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Abbott Laboratories
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Becton, Dickinson and Company
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Hologic, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 3 North America women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 15 UK women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 17 France women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 19 Italy women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 21 Spain women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Sweden women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 23 Sweden women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Norway women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 25 Norway women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Denmark women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 27 Denmark women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 31 China women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 32 China women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 34 Japan women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 36 India women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Thailand women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 38 Thailand women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 40 South Korea women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 42 Australia women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 44 Latin America women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 47 Brazil women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 49 Mexico women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 51 Argentina women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Africa women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 60 UAE women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 62 Kuwait women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)  

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Women's health diagnostics: market outlook
  • Fig. 9 Women's health diagnostics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Women's health diagnostics market driver impact
  • Fig. 15 Women's health diagnostics market restraint impact
  • Fig. 16 Women's health diagnostics market strategic initiatives analysis
  • Fig. 17 Women's health diagnostics market: Application movement analysis
  • Fig. 18 Women's health diagnostics market: Application outlook and key takeaways
  • Fig. 19 Cancer market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 20 Infectious disease market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 21 Osteoporosis market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 22 Pregnancy & fertility market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 23 Prenatal market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 24 Women's health diagnostics market: End-use movement analysis
  • Fig. 25 Women's health diagnostics market: End-use outlook and key takeaways
  • Fig. 26 Hospital market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 27 Laboratory market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 28 Homecare market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 30 Global women's health diagnostics market: Regional movement analysis
  • Fig. 31 Global women's health diagnostics market: Regional outlook and key takeaways
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 35 Europe. market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 36 UK market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 37 Germany market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 39 Italy market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 40 Spain market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 43 Denmark market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 44 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 47 India market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 48 Australia market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 51 Latin America market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 52 Brazil market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 55 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Millions)